DZ3393A1 - METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY - Google Patents

METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY

Info

Publication number
DZ3393A1
DZ3393A1 DZ013393A DZ013393A DZ3393A1 DZ 3393 A1 DZ3393 A1 DZ 3393A1 DZ 013393 A DZ013393 A DZ 013393A DZ 013393 A DZ013393 A DZ 013393A DZ 3393 A1 DZ3393 A1 DZ 3393A1
Authority
DZ
Algeria
Prior art keywords
prophylaxis
obesity
detection
treatment
compounds suitable
Prior art date
Application number
DZ013393A
Other languages
French (fr)
Inventor
Johannes Hebebrand
Jochen Antel
Ulf Freuschoff
Samuel David
Holger Sann
Michael Weske
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DZ3393A1 publication Critical patent/DZ3393A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DZ013393A 2000-07-20 2001-07-12 METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY DZ3393A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (en) 2000-07-20 2000-07-20 Selection and use of lipogenesis inhibitors for the treatment and prevention of obesity
PCT/EP2001/008051 WO2002007821A1 (en) 2000-07-20 2001-07-12 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Publications (1)

Publication Number Publication Date
DZ3393A1 true DZ3393A1 (en) 2002-01-31

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013393A DZ3393A1 (en) 2000-07-20 2001-07-12 METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY

Country Status (27)

Country Link
EP (1) EP1307262B1 (en)
JP (1) JP2004504053A (en)
KR (1) KR100818827B1 (en)
CN (1) CN1443085B (en)
AR (1) AR028730A1 (en)
AT (1) ATE278441T1 (en)
AU (2) AU7753401A (en)
BR (1) BR0112547A (en)
CA (1) CA2416647A1 (en)
CZ (1) CZ2003156A3 (en)
DE (2) DE10035227A1 (en)
DZ (1) DZ3393A1 (en)
ES (1) ES2230346T3 (en)
HK (1) HK1057499A1 (en)
HU (1) HUP0302309A3 (en)
IL (2) IL153971A0 (en)
MX (1) MXPA02012907A (en)
NO (1) NO20030233L (en)
NZ (1) NZ523960A (en)
PL (1) PL201165B1 (en)
PT (1) PT1307262E (en)
RU (1) RU2268721C2 (en)
SK (1) SK287607B6 (en)
TR (1) TR200402670T4 (en)
TW (1) TWI274157B (en)
UA (1) UA74588C2 (en)
WO (1) WO2002007821A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007538054A (en) 2004-05-19 2007-12-27 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング Drug containing N-sulfamoyl-N'-arylpiperazine for the prevention or treatment of obesity and related diseases
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CA2609185A1 (en) 2005-05-20 2006-11-30 Ahmed F. Abdel-Magid Process for preparation of sulfamide derivatives
TW200804393A (en) 2005-11-14 2008-01-16 Solvay Pharm Gmbh Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
AR058389A1 (en) * 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
NZ579229A (en) 2007-01-25 2011-07-29 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
MX2011000090A (en) 2008-06-23 2011-03-02 Janssen Pharmaceutica Nv Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems.
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
BR112014029308A2 (en) * 2012-05-24 2017-06-27 Verva Pharmaceuticals Ltd a method of improving liver function
CN106770611B (en) * 2016-12-22 2019-01-29 广西师范大学 A method of entering mitochondria for cell in-situ detection small molecule compound
RU2771430C1 (en) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Method for the quantitative determination of anticonvulsants in the blood plasma of patients with epilepsy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DE69305091T2 (en) * 1992-10-29 1997-03-13 Genentech Inc METHOD FOR TREATING OR PREVENTING OBESITY
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
ATE224189T1 (en) * 1996-06-28 2002-10-15 Ortho Mcneil Pharm Inc ANTICONVULSIVE SULFAMATE DERIVATIVES FOR THE TREATMENT OF OBESITY
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
KR20030022284A (en) 2003-03-15
DE50104023D1 (en) 2004-11-11
SK612003A3 (en) 2003-06-03
MXPA02012907A (en) 2003-09-22
ATE278441T1 (en) 2004-10-15
TR200402670T4 (en) 2004-11-22
NZ523960A (en) 2004-12-24
TWI274157B (en) 2007-02-21
CN1443085B (en) 2010-04-28
NO20030233L (en) 2003-03-19
IL153971A (en) 2009-07-20
ES2230346T3 (en) 2005-05-01
HK1057499A1 (en) 2004-04-08
PT1307262E (en) 2004-12-31
WO2002007821A1 (en) 2002-01-31
RU2268721C2 (en) 2006-01-27
JP2004504053A (en) 2004-02-12
BR0112547A (en) 2003-07-01
CZ2003156A3 (en) 2003-06-18
AR028730A1 (en) 2003-05-21
HUP0302309A2 (en) 2003-11-28
PL363518A1 (en) 2004-11-29
DE10035227A1 (en) 2002-01-31
CA2416647A1 (en) 2003-01-20
NO20030233D0 (en) 2003-01-17
EP1307262B1 (en) 2004-10-06
CN1443085A (en) 2003-09-17
EP1307262A1 (en) 2003-05-07
IL153971A0 (en) 2003-07-31
AU7753401A (en) 2002-02-05
AU2001277534B2 (en) 2005-09-29
PL201165B1 (en) 2009-03-31
KR100818827B1 (en) 2008-04-01
UA74588C2 (en) 2006-01-16
HUP0302309A3 (en) 2005-06-28
AU2001277534B9 (en) 2006-02-23
SK287607B6 (en) 2011-03-04

Similar Documents

Publication Publication Date Title
DZ3393A1 (en) METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY
FR2785521B1 (en) SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES
FR2781168B1 (en) WATER TREATMENT PROCESS AND INSTALLATION
FR07C0046I2 (en) BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
MA26889A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE CHRONIC AND / OR NEUROPATHIC PAIN AND MIGRAINES
CH1143977H1 (en) 2-Oxy-benzoxazine-4-ones for the treatment of obesity
FR2733512B1 (en) PROCESS FOR INHIBITING OR DELAYING THE FORMATION, GROWTH AND / OR AGGLOMERATION OF HYDRATES IN PRODUCTION EFFLUENTS
FR2830962B1 (en) IMAGE PROCESSING DEVICE AND METHOD FOR DETECTION OF EVOLUTIVE LESIONS
FR2775078B1 (en) METHOD AND DEVICE FOR THE TREATMENT OF DISHWASHER IN DISHWASHER
FR2816513B1 (en) SUBCUTANEOUS VALVE FOR THE TREATMENT OF HYDROCEPHALIA AND ITS ADJUSTMENT DEVICES
DZ3014A1 (en) Medicines for the treatment of hypertension.
FR2815541B1 (en) USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY
FR2785898B1 (en) PROCESS AND INSTALLATION FOR SANITATION OF BASIN WATERS SUCH AS POOL WATERS
FR2728142B1 (en) COMPOSITION FOR THE ANTI-GERMINATING TREATMENT OF TUBERS OR BULBS; TREATMENT PROCESS
FR2795398B1 (en) PROCESS AND PLANT FOR THE TREATMENT OF AGRICULTURAL EFFLUENTS
MA26592A1 (en) METHOD AND MEDICAMENT USING CYCLIC COMPOUNDS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY
FR2710073B1 (en) Apparatus allowing the reactivation and the programmed distribution of lyophilized bacteria for the treatment of effluents.
FR2724376B1 (en) PROCESS OF IN SITU TREATMENT OF SEDIMENTS AND IN PARTICULAR VASES
FR2816611B1 (en) WASTEWATER TREATMENT PROCESS
FR2752834B1 (en) IMPROVED PROCESS FOR GIVING HYDROPHOBIC PROPERTIES TO THE SURFACES OF SILICAOUS ARTICLES
FR2800628B3 (en) PROCESS FOR THE TREATMENT OF GASEOUS EFFLUENTS AND FUMES
FR2804861B1 (en) ASSISTANCE DEVICE FOR THE ELDERLY OR DISABLED
FR2813808B1 (en) PROCESS AND DEVICE FOR THE TREATMENT OF WASTE
FR2825696B1 (en) MATERIAL AND METHOD FOR THE TREATMENT OF PHOTOGRAPHIC EFFLUENTS
FR2828189B1 (en) PROCESS FOR TREATING EFFLUENTS FROM NON-COLLECTIVE SANITATION